Eric Lai
Scientific Lead, Nih Radx and Itap Initiatives @The National Institutes of Health
Signup · Get unlimited contacts
WORK HISTORY
Scientific Lead, Nih Radx and Itap Initiatives @The National Institutes of Health
Scientific Lead and Clinical Trial Lead support for 12 COVID-only OTC test EUAs, 16 POC and OTC multiplexed COVID-19/influenza tests including one OTC de novo, one Mpox POC test, one Mpox home collection kit, and one HCV POC de novo and CLIA-waived product.
EDUCATION
University of Waterloo
B.Sc., Chemistry, Computer Science
Caltech
Post-Doctoral training, Human Genetics
Columbia University Vagelos College of Physicians and Surgeons
Ph.D.,, Pharmacology
SKILLS
ABOUT ERIC LAI
20+ years of knowledge and experience in the application of genetics and genomics throughout drug development process. VP and project leader in charge of the first successful Pharmacogenetics project (Abacavir) from “Biomarker Discovery to Drug Label Update and Clinical Utility”.3 years of experience in medical device IVD development. Two PMAs and four 510k.6 years of academic faculty experience in Pharmacology and Human Genetics.Extensive knowledge in the application of genetics and genomics platforms and assays, molecular biomarker development/validation and clinical diagnostics development.Established relationships with executives in Pharma/BioTech companies, regulators and clinical key opinion leaders through collaborations, alliances and presentations.Specialties: Human Genetics, Drug Development, Pharmacogenetics, Companion Diagnostics, IVD development, Instrumentation Development and Public Private Partnership.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.